313 related articles for article (PubMed ID: 19136106)
1. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
[TBL] [Abstract][Full Text] [Related]
2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
3. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?
Konda VJ; Ross AS; Ferguson MK; Hart JA; Lin S; Naylor K; Noffsinger A; Posner MC; Dye C; Cislo B; Stearns L; Waxman I
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):159-64. PubMed ID: 18096439
[TBL] [Abstract][Full Text] [Related]
4. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
7. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
Sujendran V; Sica G; Warren B; Maynard N
Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of high-grade dysplasia in Barrett's esophagus.
Rice TW; Falk GW; Achkar E; Petras RE
Am J Gastroenterol; 1993 Nov; 88(11):1832-6. PubMed ID: 8237928
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of esophageal high-grade dysplasia.
Reed MF; Tolis G; Edil BH; Allan JS; Donahue DM; Gaissert HA; Moncure AC; Wain JC; Wright CD; Mathisen DJ
Ann Thorac Surg; 2005 Apr; 79(4):1110-5; discussion 1110-5. PubMed ID: 15797034
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer.
Moraca RJ; Low DE
Arch Surg; 2006 Jun; 141(6):545-9; discussion 549-51. PubMed ID: 16785354
[TBL] [Abstract][Full Text] [Related]
11. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
[TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view.
Romagnoli R; Collard JM; Gutschow C; Yamusah N; Salizzoni M
J Am Coll Surg; 2003 Sep; 197(3):365-71. PubMed ID: 12946790
[TBL] [Abstract][Full Text] [Related]
14. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
Reid BJ; Blount PL; Feng Z; Levine DS
Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
[TBL] [Abstract][Full Text] [Related]
15. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
16. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.
Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC
Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
18. Controversies in Barrett's esophagus: management of high grade dysplasia.
Sharma P
Semin Gastrointest Dis; 2001 Jan; 12(1):26-32. PubMed ID: 11215852
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
20. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
